Applied Genetic Technologies (AGTC) Misses Q4 EPS by 24c, Miss on Revenues
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
Go back to Applied Genetic Technologies (AGTC) Misses Q4 EPS by 24c, Miss on Revenues
September 13, 2017 4:27 PM EDT
Stifel lowered its price target on Applied Genetic Technologies Corp. (NASDAQ: AGTC) to $12.00 (from $15.00) while maintaining a Buy rating following the company's 4Q. Net loss of $3.2M, or $(0.18)/share, was wider than the Consensus estimate of $0.08. Lower-than-anticipated collaborative revenue drove the majority of the... More
September 13, 2017 12:05 PM EDT
(Updated - September 13, 2017 12:07 PM EDT)
(correction: price target lowered not raised)
BMO Capital lowered its price target on Applied Genetic Technologies Corp. (NASDAQ: AGTC) to $7 (from $14) while maintaining a Outperform rating.
Analyst Matthew Luchini cited a lower probability of success for the lead XLRS program to 40% from 70%.
...
More
September 13, 2017 9:39 AM EDT
H.C. Wainwright lowered its price target on Applied Genetic Technologies Corp. (NASDAQ: AGTC) to $8.00 (from $16.00) while maintaining a Buy rating.
Analyst Joseph Pantginis said while programs are chugging along, timelines were pushed out again.
...
More
